Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;4(4):572-83.
doi: 10.18632/oncotarget.964.

Exomic sequencing of four rare central nervous system tumor types

Affiliations

Exomic sequencing of four rare central nervous system tumor types

Chetan Bettegowda et al. Oncotarget. 2013 Apr.

Abstract

A heterogeneous population of uncommon neoplasms of the central nervous system (CNS) cause significant morbidity and mortality. To explore their genetic origins, we sequenced the exomes of 12 pleomorphic xanthoastrocytomas (PXA), 17 non-brainstem pediatric glioblastomas (PGBM), 8 intracranial ependymomas (IEP) and 8 spinal cord ependymomas (SCEP). Analysis of the mutational spectra revealed that the predominant single base pair substitution was a C:G>T:A transition in each of the four tumor types. Our data confirm the critical roles of several known driver genes within CNS neoplasms, including TP53 and ATRX in PGBM, and NF2 in SCEPs. Additionally, we show that activating BRAF mutations play a central role in both low and high grade glial tumors. Furthermore, alterations in genes coding for members of the mammalian target of rapamycin (mTOR) pathway were observed in 33% of PXA. Our study supports the hypothesis that pathologically similar tumors arising in different age groups and from different compartments may represent distinct disease processes with varied genetic composition.

PubMed Disclaimer

Figures

Figure 1A
Figure 1A. Pleomorphic xanthoastrocytoma (WHO grade II).
Pleomorphic xanthoastrocytoma represents a distinctive glioma subtype. Histologically it is characterized by the presence of nuclear pleomorphism (e.g. variation in nuclear size), a fascicular arrangement of cells and eosinophilic granular bodies (arrow).
Figure 1B
Figure 1B. Pediatric glioblastoma (WHO grade IV).
Morphologic features of pediatric glioblastomas are similar to those found in adult patients. Pseudopalisading necrosis is a characteristic finding (center), and diagnostic of glioblastoma when present in a mitotically active infiltrating astrocytoma.
Figure 1C
Figure 1C. Intracranial ependymoma (WHO grade III).
Perivascular pseudorosettes are a histologic hallmark of ependymoma, and represent neoplastic cell processes surrounding intratumoral vessels. Brisk mitotic activity is present in this intracranial ependymoma (arrows), which suffices to classify it as anaplastic.
Figure 1D
Figure 1D. Spinal cord ependymoma (WHO grade II).
Spinal cord ependymomas are typically low grade, and demonstrate low proliferative activity. Perivascular pseudorosettes, composed of numerous perivascular glial processes (arrows), are frequent characteristic histologic features.

References

    1. Cancer Facts & Figures American Cancer Society. 20122012
    1. Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, et al. The genetic landscape of the childhood cancer medulloblastoma. Science. 2011;331(331):435–439. - PMC - PubMed
    1. Rausch T, Jones DT, Zapatka M, Stutz AM, Zichner T, Weischenfeldt J, Jager N, Remke M, Shih D, Northcott PA, Pfaff E, Tica J, Wang Q, Massimi L, Witt H, Bender S, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell. 148(1-2):59–71. - PMC - PubMed
    1. Jones DT, Jager N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stutz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, Pleier S, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature. 2012;488(488):100–105. - PMC - PubMed
    1. Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, Phoenix TN, Hedlund E, Wei L, Zhu X, Chalhoub N, Baker SJ, Huether R, Kriwacki R, Curley N, Thiruvenkatam R, et al. Novel mutations target distinct subgroups of medulloblastoma. Nature. 488(488):43–48. - PMC - PubMed

Publication types